{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:59:11Z","timestamp":1791219551751,"version":"4.1.0"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Adrenal lesions are becoming increasingly common with the advent of abdominal imaging. Although mostly benign and nonfunctional, some cases may be malignant or secretory and justify adrenalectomy. The 2023 European guidelines propose a more conservative approach (focused on simple radiological criteria) to limit unnecessary surgery. However, the impact of this strategy on the management of malignant lesions remains to be assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a single-center retrospective study including all patients who underwent adrenalectomy between 2017 and 2024. The aim was to investigate the potential impact of the new iconographic criteria of the 2023 European recommendations. Patients aged over 18 years with at least one preoperative imaging examination and a histopathology report were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 259 patients, 75% had benign lesions, and 25% had malignant lesions. Based on the 2016 guidelines, 71% of the patients would have undergone surgery, whereas 31% would have undergone surgery according to the 2023 criteria. With respect to malignant lesions, 98% of the patients would have received surgery according to the 2016 criteria, whereas 60% would have received surgery according to the 2023 criteria. The inclusion of hypersecretion increased this rate to 93%, and the addition of complementary imaging ensured the detection of all malignant cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The 2023 guidelines may substantially reduce unnecessary adrenalectomies for benign lesions. The risk of missing malignant tumors remains low when hormonal evaluation and multimodal imaging (such as MRI and FDG-PET) are used, particularly in indeterminate cases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvag179","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:26:16Z","timestamp":1789755976000},"page":"541-548","source":"Crossref","is-referenced-by-count":0,"title":["Multimodal imaging for adrenal tumor characterization: clinical impact of the 2023 European guidelines\u2014asingle-center retrospective study"],"prefix":"10.1093","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5191-2101","authenticated-orcid":false,"given":"Esther","family":"Lutz","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetology and Nutrition, University Hospital of Nancy , Nancy F-54000 ,","place":["France"]},{"name":"Faculty of Medicine of Nancy, University of Lorraine , Nancy F-54000 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2050-3591","authenticated-orcid":false,"given":"Timoth\u00e9e","family":"Zaragori","sequence":"additional","affiliation":[{"name":"Meurthe-et-Moselle, CIC 1433, Inserm, Universit\u00e9 de Lorraine, CHRU Nancy , Nancy F-54000 ,","place":["France"]},{"name":"Meurthe-et-Moselle, IADI, U1254, Inserm, Universit\u00e9 de Lorraine , Nancy F-54000 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Nomin\u00e9-Criqui","sequence":"additional","affiliation":[{"name":"Faculty of Medicine of Nancy, University of Lorraine , Nancy F-54000 ,","place":["France"]},{"name":"Department of Digestive, Hepatobiliary and Endocrine Surgery, University Hospital of Nancy , Nancy F-54000 ,","place":["France"]},{"name":"INSERM UMR_S 1256, Nutrition, Genetics, and Environmental Risk Exposure (NGERE), Faculty of Medicine of Nancy, University of Lorraine , Nancy F-54000 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Marie","sequence":"additional","affiliation":[{"name":"Faculty of Medicine of Nancy, University of Lorraine , Nancy F-54000 ,","place":["France"]},{"name":"Department of Nuclear Medicine and Nancyclotep Platform, University Hospital of Nancy , Nancy F-54000 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Klein","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Nutrition, University Hospital of Nancy , Nancy F-54000 ,","place":["France"]},{"name":"Faculty of Medicine of Nancy, University of Lorraine , Nancy F-54000 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2817-980X","authenticated-orcid":false,"given":"Nicolas","family":"Scheyer","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Nutrition, University Hospital of Nancy , Nancy F-54000 ,","place":["France"]},{"name":"Faculty of Medicine of Nancy, University of Lorraine , Nancy F-54000 ,","place":["France"]},{"name":"INSERM UMR_S 1256, Nutrition, Genetics, and Environmental Risk Exposure (NGERE), Faculty of Medicine of Nancy, University of Lorraine , Nancy F-54000 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"issue":"585","key":"2026100512311045300_lvag179-B1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.actpha.2019.02.004","article-title":"Les glandes surre\u0301nales, r\u00f4e et dysfonctionnement","volume":"58","author":"Turquetil","year":"2019","journal-title":"Actual Pharm"},{"issue":"4","key":"2026100512311045300_lvag179-B2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/BF03344099","article-title":"Prevalence of adrenal incidentaloma in a contemporary computerized tomography series","volume":"29","author":"Bovio","year":"2006","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2026100512311045300_lvag179-B3","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.25.33559","article-title":"Prevalence of malignancy among incidental indeterminate adrenal nodules on contrast-enhanced CT in patients without known cancer: a multiinstitutional study","volume":"226","author":"Corwin","year":"2026","journal-title":"AJR Am J Roentgenol"},{"key":"2026100512311045300_lvag179-B4","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.200.3.8756925"},{"issue":"3","key":"2026100512311045300_lvag179-B5","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.ejrad.2008.12.010","article-title":"Differentiation of adrenal adenomas from nonadenomas using CT histogram analysis method: a prospective study","volume":"73","author":"Halefoglu","year":"2010","journal-title":"Eur J Radiol"},{"key":"2026100512311045300_lvag179-B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviscsurg.2014.07.002"},{"issue":"5","key":"2026100512311045300_lvag179-B7","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1210\/jc.2008-2302","article-title":"18F-fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients","volume":"94","author":"Groussin","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026100512311045300_lvag179-B8","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1007\/s00259-008-0849-3","article-title":"Does 18F-FDG PET\/CT add diagnostic accuracy in incidentally identified non-secretingadrenal tumours?","volume":"35","author":"Tessonnier","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"2026100512311045300_lvag179-B9","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026100512311045300_lvag179-B10","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026100512311045300_lvag179-B11","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jchirv.2014.08.007","article-title":"Complications de la surre\u0301nalectomie laparoscopique: e\u0301tude prospective de 462 interventions conse\u0301cutives","volume":"151","author":"Sebag","year":"2014","journal-title":"J Chir Visc"},{"issue":"3","key":"2026100512311045300_lvag179-B12","doi-asserted-by":"publisher","first-page":"536","DOI":"10.2214\/AJR.14.12941","article-title":"Characterization of adrenal lesions at chemical-shift MRI: a direct intraindividual comparison of in- and opposed phase imaging at 1.5 T and 3 T","volume":"204","author":"Ream","year":"2015","journal-title":"Am J Roentgenol"},{"key":"2026100512311045300_lvag179-B13","doi-asserted-by":"publisher","first-page":"S310","DOI":"10.1016\/S1166-7087(10)70047-6","article-title":"Tumeurs malignes de la surre\u0301nale: contribution du CCAFU au re\u0301fe\u0301rentiel INCa","volume":"20","author":"Se\u0300be","year":"2010","journal-title":"Prog En Urol"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvag179\/71292306\/lvag179.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/195\/4\/541\/71292306\/lvag179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/195\/4\/541\/71292306\/lvag179.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:31:19Z","timestamp":1791217879000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/195\/4\/541\/8825340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10,5]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvag179","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,21]]}}}